Rua trims FY25 loss as revenue climbs and Czechia launch boosts EU push | Cannabiz
Rua Bioscience FY25 results show revenue growth and a narrowed loss as the company marks a major European milestone with its Czechia launch.
The Heartbeat of World events
Rua Bioscience FY25 results show revenue growth and a narrowed loss as the company marks a major European milestone with its Czechia launch.
